EcoDrugPlus

Protein Farnesyltransferase/geranylgeranyltransferase Type-1 Subunit Alpha-Like

Ensembl ID : ENSAOCG00000011677
Gene Symbol: LOC111572193
3 Cross references
221 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSAOCG00000013916
Gene Symbol: PRKCA
3 Cross references
212 Possible Orthologues:

Protein Kinase C Beta Type

Ensembl ID : ENSAOCG00000018847
Gene Symbol: LOC111581447
3 Cross references
205 Possible Orthologues:

Protein Kinase C Beta Type-Like

Ensembl ID : ENSAOCG00000019972
Gene Symbol: LOC111583345
2 Cross references
177 Possible Orthologues:

Protein Kinase C Beta Type-Like

Ensembl ID : ENSAOCG00000016890
Gene Symbol: LOC111586813
2 Cross references
208 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSAOCG00000008454
Gene Symbol: PRKCD
3 Cross references
206 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSAOCG00000005330
Gene Symbol: PRKCD
3 Cross references
204 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSAOCG00000021738
Gene Symbol: PRKCE
3 Cross references
250 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSAOCG00000015671
Gene Symbol: PRKCE
3 Cross references
259 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSAOCG00000007835
Gene Symbol: PRKCH
3 Cross references
223 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSAOCG00000023437
Gene Symbol: PRKCI
3 Cross references
270 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSAOCG00000017794
Gene Symbol: PRKCQ
3 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).